My watch list
my.bionity.com  
Login  

03-01-2010: Oriola-KD Corporation has acquired the remaining 25 per cent of the shares in Foreti Oy, which owns the Moscow-based pharmaceutical retail company OOO Vitim and the pharmaceutical wholesale company OOO Moron. After the acquisition Oriola-KD owns 100 per cent of its Russian subsidiaries.

Oriola-KD acquired 75 per cent of the Russian companies in April 2008. The acquisition price for the remaining 25 per cent is EUR 65.0 million (USD 95.0 million). The total purchase price paid for the Russian companies is EUR 153.7 million (USD 226.0 million) in cash. In addition Oriola-KD has provided the Russian companies with long-term financing amounting to approximately EUR 65 million (USD 95 million).

In 2009 the net sales of Russian pharmaceutical retail and wholesale operations were EUR 480.7 million (2008 pro forma EUR 414.9 million) and operating profit was EUR 44.5 million (2008 pro forma EUR 7.4 million). The Russian companies had 3023 (3482) employees at the end of 2009.

"Our partnership during the last two years with the founders of the Russian companies has contributed very positively to the success of the businesses. Sizeable investments and joint efforts to improve operations have enabled the growth and the increased efficiency", said Eero Hautaniemi, President and CEO, Oriola-KD Corporation.

Contact / Request information

Request further information free of charge:

Watchlist

This is where you can add this news to your personal favourites

Facts, background information, dossiers
  • Oriola-KD
More about Oriola-KD
  • News

    Changes in Oriola-KD's Group Management Team

    "Oriola-KD's pharmacy chain in Sweden, Kronans Droghandel, moves into a new phase with focus on improved profitability and operational stability. Mr Jonas Levin, Marketing Director of Kronans Droghandel has been appointed Acting Managing Director of the pharmacy chain on 15 August 2011. Mr ... more

    Changes in Oriola-KD's Group Management Team

    Mr. Vladimir Knyazev, General Director of Oriola-KD's Pharmaceutical Wholesale business in Russia (OOO Moron) and member of Oriola-KD's Group Management leaves Oriola-KD on 2 November 2010. Mr. Henry Fogels, General Director of Oriola-KD's Pharmaceutical Retail business in Russia (OOO Viti ... more

    Oriola-KD Corporation has completed the sale of its Healthcare Trade business to Mediq N.V.

    The transaction of Oriola-KD Group's Healthcare Trade business to Dutch stock listed company Mediq N.V. has been completed. Mediq has paid EUR 85 million in cash for the acquisition to Oriola-KD on 31 May 2010. Oriola-KD will record a profit of approximately EUR 60 million from the sale of ... more

  • Companies

    Oriola-KD Corporation

    Oriola-KD Corporation is the parent company of the Oriola-KD Group, which is divided up into the following business segments: - Pharmaceutical Trade - Healthcare and Dental Trade Oriola-KD distributes and sells pharmaceuticals in Finland, Sweden, Denmark, Estonia and Latvia. In Lithuania, ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE